Skip to main content
Premium Trial:

Request an Annual Quote

UK Biobank Chooses Trinean's DropSense96 for Quality Control in Genotyping Study

NEW YORK (GenomeWeb) – Belgian instrument maker Trinean today announced that the UK Biobank has chosen the firm's DropSense96 droplet reader to quantify molecules during the DNA extraction stage of a large genotyping project.

The DropSense96, a multichannel spectrophotometer for spectral analysis of microliter droplets, quantifies biological molecules such as DNA, RNA, and proteins. The instrument measures DNA concentration and purity to find high-quality samples to be genotyped.

"The DropSense96 was selected in the DNA extraction workflow as it is readily automated and provided a means to extract and quantify a full plate of 96 samples in a single process, without the need for reagents," Samantha Murphy, UK Biobank senior project manager for genotyping, said in a statement.

The UK Biobank's project will genotype 500,000 samples to better understand the interaction of environment and genetic factors contributing to human diseases. In 2013, the biobank signed a contract with Affymetrix to create chip arrays to genotype the samples.

The Scan

Time to Act

A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian.

Fulgent Seeking Defamation Suit

Fulgent Genetics says it plans to sue Los Angeles County Sheriff Alex Villanueva for defamation, the Los Angeles Times reports.

Speeding Gene-Edited Crops

Reuters reports that China's new trial rules will make it easier to grow gene-edited crops there.

Nucleic Acids Research Papers on Viral Recombination, Pan-Cancer Mutations, SARS-CoV-2 Variability

In Nucleic Acids Research this week: updated pipeline to detect viral recombination, mutational patterns in tumor samples, and more.